A new research report from RNCOS titled, “Global Pharmaceutical Market Forecast to 2012”, says that the market niche for developing countries is especially phenomenal and huge growth can be expected from these countries in the coming future.
Though the global pharma industry had experienced a decline in growth over the past few years, but factors like the rising prevalence of diseases worldwide and rising per capita income are fuelling the growth and the industry is likely to grow at a CAGR of 6.5% during the forecast period.
Our research identified that, the market is especially inclined to stupendous growth in the performance of the generics market across the globe. As such, generics are expected to dominate in the near future and developments in this segment are also expected to be high. Growth has been much faster in countries, such as India, China, Brazil, and Russia, while the US and Western European countries witnessed a decline in growth. Throughout the world, the pharma industry witnessed many acquisitions, especially the larger companies acquiring smaller bases to expand their market.
The global pharma is laid out extensively providing forecasts and detailed analysis covering key geographic regions, such as North America, Latin America, and Europe amongst others. Substantial forecasts for the pharma markets in these countries are likely to provide readers with an exhaustive knowledge of the industry’s performance during the forecast period.
The report, “Global Pharmaceutical Market Forecast to 2012”, provides extensive information on the leading drugs and therapies in the pharma market globally. It also covers company profiles of key market players along with recent developments of the market leaders. The report is an excellent read-out for a holistic understanding of the industry to our clients that helps them to take informed decisions prior to investments in the market for maximum growth.
For more information visit: http://www.rncos.com/Report/IM149.htm |
